TTM
-$201M
YoY change
+36.2%
5Y CAGR
—
Peak year (FY2016)
-$16.9M
Cumulative EBITDA
-$1.47B
EBITDA history chart for Kodiak Sciences (KOD) from 2016 to 2025
Latest: -$204M
EBITDA growth chart for Kodiak Sciences (KOD) from 2016 to 2025
Latest: +36.2%
EBITDA history table for Kodiak Sciences (KOD) from 2016 to 2025
| FY2025 | -$204M | +36.2% | -$54.1M | ||
| FY2024 | -$150M | -36.3% | +$85M | ||
| FY2023 | -$235M | -27.3% | +$88.3M | ||
| FY2022 | -$323M | +25.0% | -$64.5M | ||
| FY2021 | -$258M | +100.4% | -$129M | ||
| FY2020 | -$129M | +177.4% | -$82.4M | ||
| FY2019 | -$46.4M | +31.1% | -$11M | ||
| FY2018 | -$35.4M | +35.2% | -$9.23M | ||
| FY2017 | -$26.2M | +55.3% | -$9.33M | ||
| FY2016 | -$16.9M | — | — |
- FY2025-$204M+36.2%
- FY2024-$150M-36.3%
- FY2023-$235M-27.3%
- FY2022-$323M+25.0%
- FY2021-$258M+100.4%
- FY2020-$129M+177.4%
- FY2019-$46.4M+31.1%
- FY2018-$35.4M+35.2%
- FY2017-$26.2M+55.3%
- FY2016-$16.9M—
EBITDA values are taken from Kodiak Sciences's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EBITDA at Kodiak Sciences (KOD)
According to Kodiak Sciences's latest reported financial statements, the company's current EBITDA (TTM) is -$201M. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Kodiak Sciences (KOD) most recent annual EBITDA stands at -$204M (2025) – surged 36.2% year-over-year.
The highest annual EBITDA of -$16.9M was reported in 2016. The lowest in the available history was -$323M in 2022.
Kodiak Sciences EBITDA by Year
Kodiak Sciences EBITDA 2025: -$204M
Kodiak Sciences posted EBITDA of -$204M in 2025, surged 36.2% from 2024.
Kodiak Sciences EBITDA 2024: -$150M
In 2024, Kodiak Sciences reported EBITDA of -$150M, plunged 36.3% below 2023.
Kodiak Sciences EBITDA 2023: -$235M
Kodiak Sciences EBITDA in 2023 was -$235M, declined 27.3% below 2022.
Kodiak Sciences EBITDA 2022: -$323M
2022's EBITDA for Kodiak Sciences came in at -$323M, grew 25.0% from 2021. This figure represents the lowest annual value in the available history.
Kodiak Sciences EBITDA 2021: -$258M
Kodiak Sciences EBITDA in 2021 was -$258M.
See more financial history for Kodiak Sciences (KOD).
Sector peers by EBITDA
Healthcare peers of Kodiak Sciences (KOD), ranked by their latest EBITDA
| $41.1B | |
| $28.3B | |
| $27.9B | |
| $24.4B | |
| $23.1B | |
| $17.6B | |
| $16.9B | |
| $11.5B |
- $41.1B
- $28.3B
- $27.9B
- $24.4B
- $23.1B
- $17.6B
- $16.9B
Frequently asked questions
Kodiak Sciences (KOD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.